Publications by authors named "Christophe Burm"

Claim this Profile
P
Prediction of visceral leishmaniasis development in a highly exposed HIV cohort in Ethiopia based on Leishmania infection markers: results from the PreLeisH study.
Johan van Griensven, Saskia van Henten, Aderajew Kibret, Mekibib Kassa, Hailemariam Beyene, Christophe Burm

EBioMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabies post-exposure prophylaxis: A retrospective analysis of timing of initiation and antibody responses in a Belgian cohort.
Matilde Hens, Steven Declercq, Nicole Berens-Riha, Ula Maniewski, Caroline Theunissen, Christophe Burm

Travel Med Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimalarial artesunate-mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial.
Emmanuel Bottieau, Moustapha Mbow, Isabel Brosius, Clémentine Roucher, Cheikh Tidiane Gueye, Christophe Burm

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent morbidity in Clade IIb mpox patients: interim results of a long-term follow-up study, Belgium, June to November 2022.
Nicole Berens-Riha, Stefanie Bracke, Jojanneke Rutgers, Christophe Burm, Liesbeth Van Gestel

Euro Surveill· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrEP user profiles, dynamics of PrEP use and follow-up: a cohort analysis at a Belgian HIV centre (2017-2020).
Anke Rotsaert, Thijs Reyniers, Bart K M Jacobs, Thibaut Vanbaelen, Christophe Burm

J Int AIDS Soc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.
Clémentine Roucher, Isabel Brosius, Moustapha Mbow, Babacar Thiendella Faye, Annelies De Hondt, Christophe Burm

BMJ Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis